| # | Title | Journal | Year | Citations |
|---|
| 1 | The impact of obesity on severe disease and mortality in people with SARS‐CoV‐2: A systematic review and meta‐analysis | Endocrinology, Diabetes and Metabolism | 2021 | 87 |
| 2 | The metabolic basis of nonalcoholic steatohepatitis | Endocrinology, Diabetes and Metabolism | 2020 | 64 |
| 3 | A comparative study of the binding properties, dipeptidyl peptidase‐4 (DPP‐4) inhibitory activity and glucose‐lowering efficacy of the DPP‐4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice | Endocrinology, Diabetes and Metabolism | 2018 | 61 |
| 4 | The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real‐life conditions over a period of one year | Endocrinology, Diabetes and Metabolism | 2018 | 61 |
| 5 | Gut microbiome differences between metformin‐ and liraglutide‐treated T2DM subjects | Endocrinology, Diabetes and Metabolism | 2018 | 59 |
| 6 | Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey | Endocrinology, Diabetes and Metabolism | 2021 | 53 |
| 7 | Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis | Endocrinology, Diabetes and Metabolism | 2022 | 42 |
| 8 | Prevalence of elevated liver enzymes and its association with type 2 diabetes: A cross‐sectional study in Bangladeshi adults | Endocrinology, Diabetes and Metabolism | 2020 | 39 |
| 9 | MALAT1: A regulator of inflammatory cytokines in diabetic complications | Endocrinology, Diabetes and Metabolism | 2018 | 37 |
| 10 | The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States | Endocrinology, Diabetes and Metabolism | 2019 | 37 |
| 11 | Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review | Endocrinology, Diabetes and Metabolism | 2020 | 34 |
| 12 | Drug discovery and treatment paradigms in nonalcoholic steatohepatitis | Endocrinology, Diabetes and Metabolism | 2020 | 32 |
| 13 | Risk factors for diabetic foot complications in type 2 diabetes—A systematic review | Endocrinology, Diabetes and Metabolism | 2021 | 32 |
| 14 | Footwear and insole design features for offloading the diabetic at risk foot—A systematic review and meta‐analyses | Endocrinology, Diabetes and Metabolism | 2021 | 29 |
| 15 | Early initiation of sodium‐glucose linked transporter inhibitors (SGLT‐2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients | Endocrinology, Diabetes and Metabolism | 2021 | 29 |
| 16 | Imeglimin preserves islet β‐cell mass in Type 2 diabetic ZDF rats | Endocrinology, Diabetes and Metabolism | 2021 | 29 |
| 17 | Paediatric diabetes care during the COVID‐19 pandemic: Lessons learned in scaling up telemedicine services | Endocrinology, Diabetes and Metabolism | 2021 | 28 |
| 18 | Gestational diabetes mellitus (GDM) and adverse pregnancy outcome in South Asia: A systematic review | Endocrinology, Diabetes and Metabolism | 2021 | 28 |
| 19 | Predictive scores for identifying patients with type 2 diabetes mellitus at risk of acute myocardial infarction and sudden cardiac death | Endocrinology, Diabetes and Metabolism | 2021 | 27 |
| 20 | Perspectives on youth‐onset nonalcoholic fatty liver disease | Endocrinology, Diabetes and Metabolism | 2020 | 26 |
| 21 | Stopping antibiotics after surgical amputation in diabetic foot and ankle infections—A daily practice cohort | Endocrinology, Diabetes and Metabolism | 2019 | 25 |
| 22 | Diabetes prevention interventions for women after gestational diabetes mellitus: an overview of reviews | Endocrinology, Diabetes and Metabolism | 2021 | 25 |
| 23 | Investigating the relationship between serum uric acid to high‐density lipoprotein ratio and metabolic syndrome | Endocrinology, Diabetes and Metabolism | 2022 | 25 |
| 24 | Different patterns of second‐line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study | Endocrinology, Diabetes and Metabolism | 2018 | 24 |
| 25 | The impact of coenzyme Q10 on metabolic and cardiovascular disease profiles in diabetic patients: A systematic review and meta‐analysis of randomized controlled trials | Endocrinology, Diabetes and Metabolism | 2020 | 24 |
| 26 | The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells | Endocrinology, Diabetes and Metabolism | 2021 | 24 |
| 27 | Evaluating the relationships of hypoglycaemia and HbA1c with screening‐detected diabetes distress in type 1 diabetes | Endocrinology, Diabetes and Metabolism | 2018 | 23 |
| 28 | The association of sodium‐glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews | Endocrinology, Diabetes and Metabolism | 2020 | 23 |
| 29 | Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study | Endocrinology, Diabetes and Metabolism | 2021 | 23 |
| 30 | Relationship between triglyceride glucose index, retinopathy and nephropathy in Type 2 diabetes | Endocrinology, Diabetes and Metabolism | 2021 | 23 |
| 31 | Prevalence of diabetes and cardio‐metabolic risk factors in young men in the United Arab Emirates: A cross‐sectional national survey | Endocrinology, Diabetes and Metabolism | 2019 | 22 |
| 32 | Steviol glucuronide, a metabolite of steviol glycosides, potently stimulates insulin secretion from isolated mouse islets: Studies in vitro | Endocrinology, Diabetes and Metabolism | 2019 | 21 |
| 33 | Tier 3 specialist weight management service and pre‐bariatric multicomponent weight management programmes for adults with obesity living in the UK: A systematic review | Endocrinology, Diabetes and Metabolism | 2019 | 21 |
| 34 | Short‐and long‐term administration of imeglimin counters cardiorenal dysfunction in a rat model of metabolic syndrome | Endocrinology, Diabetes and Metabolism | 2020 | 21 |
| 35 | Paediatric Anti‐Müllerian Hormone measurement: Male and female reference intervals established using the automated Beckman Coulter Access AMH assay | Endocrinology, Diabetes and Metabolism | 2018 | 20 |
| 36 | Glucose variability and mood in adults with diabetes: A systematic review | Endocrinology, Diabetes and Metabolism | 2021 | 19 |
| 37 | The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care | Endocrinology, Diabetes and Metabolism | 2020 | 18 |
| 38 | Exogenous d‐β‐hydroxybutyrate lowers blood glucose in part by decreasing the availability of L‐alanine for gluconeogenesis | Endocrinology, Diabetes and Metabolism | 2022 | 18 |
| 39 | Hepatitis B virus reactivation with corticosteroid therapy in patients with adrenal insufficiency | Endocrinology, Diabetes and Metabolism | 2019 | 17 |
| 40 | Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control | Endocrinology, Diabetes and Metabolism | 2021 | 17 |
| 41 | Assessing the clinical utility of the diabetes eating problem survey‐revised (DEPS‐R) in adolescents with type 1 diabetes | Endocrinology, Diabetes and Metabolism | 2019 | 16 |
| 42 | Adrenal vein sampling with and without cosyntropin stimulation for detection of surgically remediable aldosteronism | Endocrinology, Diabetes and Metabolism | 2019 | 16 |
| 43 | Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study | Endocrinology, Diabetes and Metabolism | 2019 | 16 |
| 44 | Standardizing the haemoglobin glycation index | Endocrinology, Diabetes and Metabolism | 2021 | 16 |
| 45 | Cardiovascular complications in COVID‐19 patients with or without diabetes mellitus | Endocrinology, Diabetes and Metabolism | 2021 | 16 |
| 46 | The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease | Endocrinology, Diabetes and Metabolism | 2020 | 15 |
| 47 | Effectiveness of interventions based on patient empowerment in the control of type 2 diabetes in sub‐Saharan Africa: A review of randomized controlled trials | Endocrinology, Diabetes and Metabolism | 2021 | 15 |
| 48 | The Impact of COVID‐19 Pandemic on Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes: A Single‐Centre Study in Central Pennsylvania | Endocrinology, Diabetes and Metabolism | 2021 | 15 |
| 49 | Impact of lifestyle Intervention on branched‐chain amino acid catabolism and insulin sensitivity in adolescents with obesity | Endocrinology, Diabetes and Metabolism | 2021 | 15 |
| 50 | Hyperglycaemia increases mortality risk in non‐diabetic patients with COVID‐19 even more than in diabetic patients | Endocrinology, Diabetes and Metabolism | 2021 | 15 |
